Back

Survival benefits of SGLT2 inhibitors in very elderly patients with heart failure with preserved ejection fraction

29 August 2026 (09:15 - 10:00)
Organised by: Logo
Congress Presentation Part of: Striving for effective heart failure therapies Heart Failure with Preserved Ejection Fraction (HFpEF) ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Yilan Ge

Beijing Hospital, Beijing (China)

4 More presentations in this session

Presentation thumbnail
Mendelian randomization unravels bidirectional effects of NAFLD and heart failure across subtypes
Mr S. Huang (Beijing, CN)
Abstract Slides
Presentation thumbnail
Classification and regression tree analysis for identification of long-term risk in patients with heart failure with preserved ejection fraction. final results of the Argentine ARFEY-Preser Registry
Doctor E. Perna (Corrientes, AR)
Abstract Slides
Presentation thumbnail
Association between resting heart rate and clinical outcomes in heart failure with preserved ejection fraction: age stratified insights from the KUNIUMI Registry
Mr T. Matsuura (Kobe, JP)
Abstract Slides
Presentation thumbnail
Comparative efficacy of sodium-glucose cotransporter-2 inhibitors in heart failure with mildly reduced or preserved ejection fraction: a Bayesian network meta-analysis of randomized controlled trials
Doctor I. Zahan (Harefield, GB)
Abstract Slides

Access the full session

Session thumbnail
Striving for effective heart failure therapies

The Event

Event poster

ESC Congress 2026

29 August 2026 09:15 CET
You may be interested in
thumbnail
Congress Presentation
SGLT2 inhibitors among patients with heart failure with preserved ejection fraction: a meta analysis of randomised controlled trials
2 December 2022
thumbnail
Congress Presentation
Clinical improvement, heart failure hospitalization and survival after cardiac resynchronization therapy in elderly population
29 June 2021
thumbnail
Congress Presentation
Factors associated with oral SGLT2 inhibitor use and prognosis in elderly heart failure patients
28 August 2026
thumbnail
Congress Presentation
Impact of sodium-glucose cotransporter-2 inhibitors on survival in patients with cancer therapy-related cardiac dysfunction
20 June 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources